These data indicate that miR-UL22A, through targeting SMAD3, is important for reducing type I IFN and ISG production during lytic HCMV infection but also that other gene products are likely also involved in SMAD3 and IFN regulation. This evidence concerns the gene SMAD3 and cytomegalovirus infection.